NM_000535.7(PMS2):c.614A>C (p.Gln205Pro) AND Breast and/or ovarian cancer

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 9, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003149758.2

Allele description [Variation Report for NM_000535.7(PMS2):c.614A>C (p.Gln205Pro)]

NM_000535.7(PMS2):c.614A>C (p.Gln205Pro)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.614A>C (p.Gln205Pro)

HGVS:

NC_000007.14:g.5999199T>G
NG_008466.1:g.14908A>C
NM_000535.7:c.614A>CMANE SELECT
NM_001322003.2:c.209A>C
NM_001322004.2:c.209A>C
NM_001322005.2:c.209A>C
NM_001322006.2:c.614A>C
NM_001322007.2:c.296A>C
NM_001322008.2:c.296A>C
NM_001322009.2:c.209A>C
NM_001322010.2:c.209A>C
NM_001322011.2:c.-320A>C
NM_001322012.2:c.-320A>C
NM_001322013.2:c.133-1776A>C
NM_001322014.2:c.614A>C
NM_001322015.2:c.305A>C
NP_000526.2:p.Gln205Pro
NP_001308932.1:p.Gln70Pro
NP_001308933.1:p.Gln70Pro
NP_001308934.1:p.Gln70Pro
NP_001308935.1:p.Gln205Pro
NP_001308936.1:p.Gln99Pro
NP_001308937.1:p.Gln99Pro
NP_001308938.1:p.Gln70Pro
NP_001308939.1:p.Gln70Pro
NP_001308943.1:p.Gln205Pro
NP_001308944.1:p.Gln102Pro
LRG_161t1:c.614A>C
LRG_161:g.14908A>C
NC_000007.13:g.6038830T>G
NM_000535.5:c.614A>C
NM_000535.6:c.614A>C
NR_136154.1:n.701A>C
p.Q205P

Protein change:

Q102P

Links:

dbSNP: rs587779342

NCBI 1000 Genomes Browser:

rs587779342

Molecular consequence:

NM_001322011.2:c.-320A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-320A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322013.2:c.133-1776A>C - intron variant - [Sequence Ontology: SO:0001627]
NM_000535.7:c.614A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322003.2:c.209A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322004.2:c.209A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322005.2:c.209A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322006.2:c.614A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322007.2:c.296A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322008.2:c.296A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322009.2:c.209A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322010.2:c.209A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322014.2:c.614A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322015.2:c.305A>C - missense variant - [Sequence Ontology: SO:0001583]
NR_136154.1:n.701A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Breast and/or ovarian cancer
Identifiers:: MedGen: CN221562

Recent activity

Clear Turn Off Turn On

PREDICTED: Cucumis melo 14-3-3-like protein GF14 iota (LOC103489177), transcript...
PREDICTED: Cucumis melo 14-3-3-like protein GF14 iota (LOC103489177), transcript variant X2, mRNA
gi|2316582450|ref|XM_008448207.3|

Nucleotide
14-3-3-like protein GF14 iota isoform X1 [Cucumis melo]
14-3-3-like protein GF14 iota isoform X1 [Cucumis melo]
gi|659091208|ref|XP_008446428.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003838395	CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Feb 9, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003838395

CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Feb 9, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario, SCV003838395.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine